In both breast cancer subtypes, the level of active RAC1 was significantly higher in tumors from the recurrence groups than in those from the remission groups, the level of RAC1-GTP being low or undetectable in the latter (Figure 1A). This evidence concerns the gene RAC1 and breast cancer.